WEREWOLF THERAPEUTICS, INC.

HOWL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $57.1M $111.0M $134.3M $129.3M $157.5M $92.6M $18.1M
Accounts Receivable
Inventory
Total Current Assets $58.6M $113.1M $138.4M $140.2M $161.1M $92.9M
Property, Plant & Equipment $4.7M $6.3M $8.0M $9.0M $2.9M $651.0K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $69.4M $126.9M $174.8M $160.2M $179.3M $96.4M
Liabilities
Accounts Payable $754.0K $3.0M $1.3M $1.2M $2.0M $1.0M
Total Current Liabilities $36.1M $15.2M $19.4M $24.0M $11.9M $5.3M
Long-Term Debt $32.1M $32.1M $40.0M
Total Liabilities $44.6M $53.5M $63.5M $37.9M $26.5M $7.2M
Stockholders' Equity
Retained Earnings $-475.4M $-414.6M $-344.1M $-306.7M $-252.9M $-51.9M
Total Stockholders' Equity $24.8M $73.4M $111.4M $122.3M $152.8M $-51.9M $-24.3M